Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Asset Utilization Ratio (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Asset Utilization Ratio for 12 consecutive years, with 1.27 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 20.72% to 1.27 in Q4 2025 year-over-year; TTM through Dec 2025 was 1.27, a 20.72% decrease, with the full-year FY2025 number at 1.48, down 8.32% from a year prior.
  • Asset Utilization Ratio was 1.27 for Q4 2025 at Niagen Bioscience, down from 1.32 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.66 in Q3 2024 to a low of 1.03 in Q3 2021.
  • A 5-year average of 1.42 and a median of 1.44 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 44.59% in 2022, then decreased 20.72% in 2025.
  • Niagen Bioscience's Asset Utilization Ratio stood at 1.14 in 2021, then rose by 26.71% to 1.45 in 2022, then grew by 6.66% to 1.54 in 2023, then grew by 3.56% to 1.6 in 2024, then dropped by 20.72% to 1.27 in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Asset Utilization Ratio are 1.27 (Q4 2025), 1.32 (Q3 2025), and 1.35 (Q2 2025).